Respiratory Department, Hospital General Universitario Gregorio Marañón, Facultad de Medicina, Universidad Complutense de Madrid (UCM), Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.
Preventive Medicine and Public Health Teaching and Research Unit, Rey Juan Carlos University, Alcorcón, Madrid, Spain.
Eur J Intern Med. 2018 Nov;57:76-82. doi: 10.1016/j.ejim.2018.06.022. Epub 2018 Jun 30.
The objectives of this study were to examine incidence and in-hospital outcomes of Clostridium difficile infection (CDI) among patients with COPD, to compare clinical variables among COPD patients with matched non-COPD patients hospitalized with CDI, and to identify factors associated with in-hospital mortality (IHM) among COPD patients.
We performed a retrospective study using the Spanish National Hospital Discharge Database from 2001 to 2015. We included patients aged 40 years or over with a primary or secondary diagnosis of CDI. For each COPD patient, we selected a sex, age, readmission status and year-matched non-COPD patient.
We identified 44,695 patients with CDI (19.36% with COPD). Incidence of CDI has increased significantly from 2001 to 2015 besides COPD status. Incidence was higher in COPD patients than in patients without this disease (IRR 2.24; 95%CI 2.18-2.29). IHM decreased significantly over time in patients without COPD (from 13.98% in 2001-03 to 10.99% in 2013-15), but there were no changes in those with COPD (from 12.93% in 2001-03 to 13.37% in 2013-15). In COPD patients, higher mortality rates were associated with older age, comorbidities, severe CDI, longer length of hospital stay and readmission. Primary diagnosis of CDI was associated with lower IHM in this group of patients (OR 0.66; 95%CI 0.56-0.77) in comparison with secondary diagnosis.
Incidence of CDI was twice higher in COPD patients than in matched non-COPD controls and is increasing overtime in both groups. Our results suggest that the management of CDI has improved in Spain during the study period.
本研究的目的是调查慢性阻塞性肺疾病(COPD)患者中艰难梭菌感染(CDI)的发病率和院内结局,比较 CDI 住院 COPD 患者与匹配的非 COPD 患者的临床变量,并确定 COPD 患者院内死亡率(IHM)的相关因素。
我们使用西班牙全国住院数据库进行了一项回顾性研究,时间范围为 2001 年至 2015 年。我们纳入了年龄在 40 岁或以上的原发性或继发性 CDI 患者。对于每位 COPD 患者,我们选择了一名性别、年龄、再入院状态和年份匹配的非 COPD 患者。
我们共确定了 44695 例 CDI 患者(19.36%为 COPD 患者)。从 2001 年到 2015 年,CDI 的发病率显著增加,且 COPD 患者的发病率高于非 COPD 患者(发病率比 2.24;95%CI 2.18-2.29)。在没有 COPD 的患者中,IHM 随着时间的推移显著降低(从 2001-03 年的 13.98%降至 2013-15 年的 10.99%),但 COPD 患者没有变化(从 2001-03 年的 12.93%降至 2013-15 年的 13.37%)。在 COPD 患者中,较高的死亡率与年龄较大、合并症、严重 CDI、住院时间较长和再入院有关。与二级诊断相比,CDI 的主要诊断与该组患者较低的 IHM 相关(OR 0.66;95%CI 0.56-0.77)。
COPD 患者的 CDI 发病率是匹配的非 COPD 对照组的两倍,且在两组中都呈上升趋势。我们的结果表明,在研究期间,西班牙对 CDI 的管理有所改善。